What Are the Symptoms of Carcinoid Syndrome?
At a Glance
The primary symptoms of carcinoid syndrome are sudden skin flushing, severe diarrhea, and wheezing. These occur when a neuroendocrine tumor releases excess serotonin into the bloodstream. Doctors can diagnose this condition using a 24-hour 5-HIAA urine test and treat it with hormone-blocking medications.
Carcinoid syndrome is a collection of symptoms caused by a tumor releasing excessive amounts of hormones, most notably serotonin, into your bloodstream [1]. While often discussed alongside endocrine gland tumors, these tumors develop from specialized cells called neuroendocrine cells that are found throughout the body, most commonly in your digestive tract or lungs. While many neuroendocrine tumors do not produce hormones, those that do can trigger a specific set of disruptive physical reactions known as carcinoid syndrome [2][3].
The Classic Symptoms of Carcinoid Syndrome
The symptoms of carcinoid syndrome can vary from person to person, but they often include a classic triad of issues [3]:
- Sudden Skin Flushing: You may experience a sudden, intense redness and feeling of warmth, usually on your face, neck, or upper chest [4]. This flushing can happen spontaneously or be triggered by stress, exercise, alcohol, or eating certain trigger foods (such as heavy meals or foods high in amines, like aged cheeses).
- Severe Diarrhea: Frequent, watery bowel movements are a hallmark of carcinoid syndrome [4]. This diarrhea can be debilitating and is often accompanied by abdominal cramping or pain [3]. Living with severe diarrhea can be incredibly disruptive and emotionally exhausting, but knowing the cause is the first step toward getting treatments that can help.
- Wheezing and Shortness of Breath: You might experience a whistling sound when you breathe or feel like you cannot catch your breath, similar to asthma symptoms [4].
In addition to these symptoms, because the tumor uses up the body’s supply of tryptophan to create all this excess serotonin, some people can develop a vitamin B3 (niacin) deficiency known as pellagra [4].
How Tumors Cause These Symptoms
In a healthy body, the liver breaks down excess serotonin and other chemicals [5]. However, if a neuroendocrine tumor has spread (metastasized) to the liver or is located in a way that allows its hormones to bypass the liver’s filtering process, these active chemicals enter your general blood circulation directly [5][3].
When large amounts of serotonin and other vasoactive substances (chemicals that affect your blood vessels) flood your system, they cause the blood vessels in your skin to expand (triggering flushing), stimulate the intestines to move too quickly (causing diarrhea), and narrow the airways in your lungs (leading to wheezing) [1][6].
Long-Term Complications to Watch For
If left untreated over a long period, the constant high levels of serotonin in the blood can lead to a more serious complication known as carcinoid heart disease [7][3]. This condition occurs when scar tissue builds up on the valves of the heart, particularly on the right side, making it harder for the heart to pump blood effectively [8][9]. Your doctor can actively monitor for this by ordering regular echocardiograms (ultrasounds of the heart).
You must also be aware of the risk of a carcinoid crisis, a severe, sudden, and potentially life-threatening release of hormones [10]. This is most often triggered by physical stress such as surgery, anesthesia, or tumor biopsies [11]. It is vital to tell any surgeon or anesthesiologist about your condition beforehand so they can monitor you closely and administer medications to prevent a crisis [12].
Next Steps and Diagnosis
If you are experiencing the symptoms of carcinoid syndrome, it is important to communicate them clearly to your care team. They can diagnose the condition by testing your hormone levels, often using a 24-hour 5-HIAA urine test, which measures the breakdown products of serotonin over a full day [13][14].
Once diagnosed, your team can prescribe treatments specifically designed to block hormone production, such as somatostatin analogs (SSAs) [15][16]. These medications can significantly reduce your daily symptoms and help protect your heart from long-term damage.
Common questions in this guide
What are the most common symptoms of carcinoid syndrome?
How do doctors test for carcinoid syndrome?
What is a carcinoid crisis?
Can carcinoid syndrome affect your heart?
What treatments are available for carcinoid syndrome symptoms?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Could the symptoms I am experiencing be caused by carcinoid syndrome?
- 2.Should we perform a 24-hour 5-HIAA urine test to measure my hormone levels?
- 3.Should I get a baseline echocardiogram to check for signs of carcinoid heart disease?
- 4.Are somatostatin analogs an appropriate treatment option to help manage my diarrhea and flushing?
- 5.How can we safely manage my risk for a carcinoid crisis if I ever need surgery or a procedure requiring anesthesia?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (16)
- 1
Serotonin pathway in carcinoid syndrome: Clinical, diagnostic, prognostic and therapeutic implications.
Fanciulli G, Ruggeri RM, Grossrubatscher E, et al.
Reviews in endocrine & metabolic disorders 2020; (21(4)):599-612 doi:10.1007/s11154-020-09547-8.
PMID: 32152781 - 2
Mesenteric Fibrosis in Midgut Neuroendocrine Tumors: Functionality and Radiological Features.
Rodríguez Laval V, Pavel M, Steffen IG, et al.
Neuroendocrinology 2018; (106(2)):139-147 doi:10.1159/000474941.
PMID: 28384635 - 3
Carcinoid syndrome from a carcinoid tumor of the pancreas without liver metastases: A case report and literature review.
Zavras N, Schizas D, Machairas N, et al.
Oncology letters 2017; (13(4)):2373-2376 doi:10.3892/ol.2017.5678.
PMID: 28454406 - 4
Carcinoid Syndrome: A Review.
Gade AK, Olariu E, Douthit NT
Cureus 2020; (12(3)):e7186 doi:10.7759/cureus.7186.
PMID: 32257725 - 5
Anesthetic Management of Gastrointestinal Carcinoid Tumors: A Case Report.
Wiederholt B, Gengler T, Bendure J
AANA journal 2022; (90(5)):377-382.
PMID: 36173796 - 6
Updates on the biology of serotonin and tryptophan hydroxylase.
Swami T, Weber HC
Current opinion in endocrinology, diabetes, and obesity 2018; (25(1)):12-21 doi:10.1097/MED.0000000000000383.
PMID: 29194046 - 7
Right and Left-Sided Carcinoid Heart Disease in the Setting of Selective Serotonin Reuptake Inhibitor Use.
Bell J, Alhudairy M, Kazakova V, et al.
JACC. Case reports 2020; (2(12)):1841-1844 doi:10.1016/j.jaccas.2020.07.060.
PMID: 33106792 - 8
Carcinoid heart disease in patients with advanced small-intestinal neuroendocrine tumors and carcinoid syndrome: a retrospective experience from two European referral centers.
Algeri L, Falkman L, Spada F, et al.
ESMO open 2024; (9(11)):103959 doi:10.1016/j.esmoop.2024.103959.
PMID: 39442478 - 9
Carcinoid Heart Disease: Pathophysiology, Pathology, Clinical Manifestations, and Management.
Jin C, Sharma AN, Thevakumar B, et al.
Cardiology 2021; (146(1)):65-73 doi:10.1159/000507847.
PMID: 33070143 - 10
Perioperative management of a double valve replacement and coronary artery bypass graft in a patient with carcinoid syndrome; a case report and literature review.
Sarridou DG, Gkiouliava A, Argiriadou H, et al.
Perfusion 2025; (40(3)):766-769 doi:10.1177/02676591241247977.
PMID: 38626318 - 11
Prevention and Management of Hormonal Crisis during Theragnosis with LU-DOTA-TATE in Neuroendocrine Tumors. A Systematic Review and Approach Proposal.
Del Olmo-García MI, Muros MA, López-de-la-Torre M, et al.
Journal of clinical medicine 2020; (9(7)) doi:10.3390/jcm9072203.
PMID: 32664679 - 12
Adrenaline bolus rescue for refractory carcinoid crises during surgical manipulation of metastatic neuroendocrine tumor of pancreas: A case report.
Murugesan AM, Nandagopan NM, Senthilnathan M, Kumar MR
Saudi journal of anaesthesia 2024; (18(4)):599-601 doi:10.4103/sja.sja_319_24.
PMID: 39600460 - 13
Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome.
Kulke MH, Hörsch D, Caplin ME, et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017; (35(1)):14-23 doi:10.1200/JCO.2016.69.2780.
PMID: 27918724 - 14
Telotristat Ethyl: First Global Approval.
Markham A
Drugs 2017; (77(7)):793-798 doi:10.1007/s40265-017-0737-x.
PMID: 28382568 - 15
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors.
Kaltsas G, Caplin M, Davies P, et al.
Neuroendocrinology 2017; (105(3)):245-254 doi:10.1159/000461583.
PMID: 28253514 - 16
The role of serotonin inhibition within the treatment of carcinoid syndrome.
George J, Ramage J, White B, Srirajaskanthan R
Endocrine oncology (Bristol, England) 2023; (3(1)):e220077 doi:10.1530/EO-22-0077.
PMID: 37434648
This page provides educational information about the symptoms and complications of carcinoid syndrome. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider regarding any symptoms you experience.
Get notified when new evidence is published on Tumor of endocrine glands.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.